IP Library Patent Application 14272642
Patent Application
App. No. 14/272,642

METHODS FOR ENHANCEMENT OF MUSCLE PROTEIN SYNTHESIS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/272,642
Abstract

The present disclosure provides methods for enhancing muscle protein synthesis in an individual in need of same. Specifically, the present disclosure provides methods for enhancing muscle protein synthesis by enhancing myofibrillar muscle protein synthesis. The method includes administering to the individual a mixed macronutrient composition having (i) an amount of whey protein that is not capable of enhancing myofibrillar protein synthesis when ingested by itself and (ii) free leucine. The composition comprises at least about 5.0 g total leucine per dose.

Claims (26)

1 . A method for enhancing muscle protein synthesis or muscle anabolism in an individual in need of same, the method comprising the steps of:

administering to the individual a therapeutically effective amount of a mixed macronutrient composition having (i) an amount of whey protein that is not capable of enhancing myofibrillar protein synthesis when ingested by itself and (ii) free leucine, wherein the composition comprises at least about 5.0 g total leucine per dose, wherein the composition is administered following a resistance exercise.

2 . The method according to claim 1 , wherein the amount of whey protein is at least about 6.25 g per dose.

3 . The method according to claim 1 , wherein the amount of free leucine is at least about 4.25 g per dose.

4 . The method according to claim 1 , wherein the mixed macronutrient includes a source of carbohydrates and a source of fats.

5 . The method according to claim 1 , wherein the dose is a single bolus.

6 . The method according to claim 1 , wherein the composition is administered immediately following a resistance exercise.

7 . The method according to claim 1 , wherein the composition further comprises at least one of:

at least one source of ω-3 fatty acids selected from the group consisting of fish oil, krill, plant sources containing ω-3 fatty acids, flaxseed, walnut, algae, and combinations thereof;

at least one nucleotide selected from the group consisting of a subunit of deoxyribonucleic acid (“DNA”), a subunit of ribonucleic acid (“RNA”), polymeric forms of DNA and RNA, yeast RNA, and combinations thereof;

at least one phytonutrient selected from the group consisting of flavanoids, allied phenolic compounds, polyphenolic compounds, terpenoids, alkaloids, sulphur-containing compounds, and combinations thereof;

at least one prebiotic selected from the group consisting of acacia gum, alpha glucan, arabinogalactans, beta glucan, dextrans, fructooligosaccharides, fucosyllactose, galactooligosaccharides, galactomannans, gentiooligosaccharides, glucooligosaccharides, guar gum, inulin, isomaltooligosaccharides, lactoneotetraose, lactosucrose, lactulose, levan, maltodextrins, milk oligosaccharides, partially hydrolyzed guar gum, pecticoligosaccharides, resistant starches, retrograded starch, sialooligosaccharides, sialyllactose, soyoligosaccharides, sugar alcohols, xylooligosaccharides, their hydrolysates, and combinations thereof;

at least one probiotic selected from the group consisting of Aerococcus, Aspergillus, Bacteroides, Bifidobacterium, Candida, Clostridium, Debaromyces, Enterococcus, Fusobacterium, Lactobacillus, Lactococcus, Leuconostoc, Melissococcus, Micrococcus, Mucor, Oenococcus, Pediococcus, Penicillium, Peptostrepococcus, Pichia, Propionibacterium, Pseudocatenulatum, Rhizopus, Saccharomyces, Staphylococcus, Streptococcus, Torulopsis, Weissella , non-replicating microorganisms, and combinations thereof;

at least one antioxidant selected from the group consisting of astaxanthin, carotenoids, coenzyme Q10 (“CoQ10”), flavonoids, glutathione, Goji (wolfberry), hesperidin, lactowolfberry, lignan, lutein, lycopene, polyphenols, selenium, vitamin A, vitamin C, vitamin E, zeaxanthin, and combinations thereof;

at least one vitamin selected from the group consisting of vitamin A, Vitamin B1 (thiamine), Vitamin B2 (riboflavin), Vitamin B3 (niacin or niacinamide), Vitamin B5 (pantothenic acid), Vitamin B6 (pyridoxine, pyridoxal, or pyridoxamine, or pyridoxine hydrochloride), Vitamin B7 (biotin), Vitamin B9 (folic acid), and Vitamin B12 (various cobalamins; commonly cyanocobalamin in vitamin supplements), vitamin C, vitamin D, vitamin E, vitamin K, K1 and K2 (i.e., MK-4, MK-7), folic acid, biotin, and combinations thereof;

at least one mineral selected from the group consisting of boron, calcium, chromium, copper, iodine, iron, magnesium, manganese, molybdenum, nickel, phosphorus, potassium, selenium, silicon, tin, vanadium, zinc, and combinations thereof; or combinations thereof.

8 . The method according to claim 1 , wherein the composition is a liquid.

9 . The method according to claim 1 , wherein the nutritional composition is a tube feeding.

10 . The method according to claim 1 , wherein the nutritional composition is a source of complete nutrition.

11 . The method according to claim 1 , wherein the nutritional composition is a source of incomplete nutrition.

12 . The method according to claim 1 , wherein the individual is an athlete.

13 . The method according to claim 1 , wherein the individual is undergoing muscle rehabilitation.

14 . The method according to claim 1 , wherein the individual is undergoing physical therapy.

15 . The method according to claim 1 , wherein the individual is an elderly individual.

16 . The method according to claim 1 , wherein the individual is a young adult.

17 . The method according to claim 1 , wherein the nutritional composition is formulated for administration to an individual selected from one of an infant, a child, a young adult, an elderly adult, an athlete, and combinations thereof.

Assignments (4)
ASSIGNMENT AND ASSUMPTION OF AFTER-ACQUIRED INTELLECTUAL PROPERTY SECURITY AGREEMENT (FOURTH SUPPLEMENTAL FILING) DATED AS 2/9/2015 AND RECORDED WITH THE USPTO ON 2/19/2015 Recorded May 13, 2015
From: WELLS FARGO BANK, NATIONAL ASSOCIATION AS RESIGNING ADMINISTRATIVE AGENT
To: BARCLAYS BANK PLC, AS SUCCESSOR ADMINISTRATIVE AGENT
Reel/Frame 035652/0786 →
AFTER-ACQUIRED INTELLECTUAL PROPERTY SECURITY AGREEMENT (FOURTH SUPPLEMENTAL FILING) Recorded Feb 19, 2015
From: PREMIER NUTRITION CORPORATION
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 035049/0080 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 4, 2014
From: NESTEC S.A.
To: PREMIER NUTRITION CORPORATION
Reel/Frame 034102/0283 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 6, 2014
From: BREUILLE, DENIS; STELLINGWERFF, TRENT; MOORE, DANIEL RYAN; OFFORD CAVIN, ELIZABETH ANN; PHILLIPS, STUART MARTIN
To: NESTEC S.A.
Reel/Frame 033474/0403 →